Red Door Wealth Management, LLC Geron Corp Transaction History

Red Door Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$1.2 - $1.5 $12 - $15	-10 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$1.25 - $1.83 $12 - $18	10 New	10 $0
Q3 2020 Oct 14, 2020	SELL	$1.59 - $2.19 $15 - $21	-10 Closed	0 $0
Q1 2020 Apr 20, 2020	BUY	$0.89 - $1.49 $8 - $14	10 New	10 $0

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.54B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Red Door Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Red Door Wealth Management, LLC with notifications on news.